New York, NY -- (SBWIRE) -- 02/08/2013 -- Growing Stock Report adds EnteroMedics Inc. (NASDAQ:ETRM) and Guidance Software, Inc. (NASDAQ:GUID) to their NASDAQ Decliners Watch List.
EnteroMedics Inc. (NASDAQ:ETRM) a clinical development stage medical device company that focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders is currently down (-55.98%) as shares of EnteroMedics Inc. plunged Friday after the company reported disappointing clinical trial results for its Maestro system, which is designed use nerve stimulation to help obese people lose weight. With this huge percentage decline in stock price, Growing Stock Report adds EnteroMedics Inc. (NASDAQ:ETRM) to their NASDAQ Decliners Watch List.
Click Here to find out what other Investors are saying about EnteroMedics Inc.
Guidance Software, Inc. (NASDAQ:GUID) a company that provides digital investigative solutions to government agencies and corporations primarily in the Americas, Europe, the Middle East, Africa, and Asia/the Pacific Rim is currently down (-20.40%) on 1,203,409 shares traded which is way above their average daily volume of 59,361. It is down (-31.27%) from its 52-week high which has prompted Growing Stock Report to add Guidance Software, Inc. (NASDAQ:GUID) to their NASDAQ Decliners Watch List.
Click Here to see what other investors are saying about Guidance Software, Inc.
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Contact Info:
Growing Stock Report
editor@GrowingStockReport.com
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)